None listed
Conditions
Interventions
Intervention1: syp. Mefenamic Acid: 4mg/kg dose stat 30 minutes prior to vaccination
Control Intervention1: Placebo: 4mg/kg dose stat 30 minutes prior to vaccination
Control Intervention2: Syp Paracet
Sponsors
Dr Rachna Pasi
Dr Arun Babu T
Eligibility
Inclusion criteria
Inclusion criteria: Children who will be coming for routine vaccination as per National immunization schedule and whose parents will give written informed consent to participate in this study.
Exclusion criteria
Exclusion criteria: 1.All children whose parents will not give consent to participate. 2.Children who will be having any liver or kidney diseases and coagulation disorders. 3.Children with past history of any allergic reactions. 4.Children in whom pain assessment could not be satisfactorily done
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effect of mefenamic acid or paracetamol as prophylactic analgesic in pain management in children during vaccination using FLACC scale.Timepoint: At time of vaccination 15 minutes after vaccination 30 minutes after vaccination | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the effect of mefenamic acid or paracetamol on systemic symptoms after vaccinationTimepoint: 24 hours after vaccination | — |
Countries
India
Contacts
Public ContactDr Arun Babu T
AIIMS, Mangalagiri
Outcome results
None listed